1 completed, 1 terminated. 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Chromosome 15q, trisomy: new trials by email Literature Review of Chromosome 15q, trisomy trials Research Report on Chromosome 15q, trisomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome Basmisanil, Placebo - Dup15q Syndrome | Phase 2 | Terminated | Hoffmann-La Roche | 7 | 2022-12-16 | 2026-08-18 |
| Angelman Syndrome (AS) Biomarker Study Lumbar Puncture, Blood Collection - Angelman Syndrome, Chromosome 15q Duplication (dup15q) Syndrome | Early Phase 1 | Completed | Biogen | 20 | 2019-12-18 | 2022-01-28 |
Polyposis Syndrome, Hereditary Mixed, 1 (2) · Angelman Syndrome (1) · Syndrome (1)
Abnormalities, Multiple (1) · Central Nervous System Diseases (1) · Chromosome Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disease (1) · Genetic Diseases, Inborn (1) · Imprinting Disorders (1) · Movement Disorders (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Blood Specimen Collection (1) · Spinal Puncture (1) · basmisanil (1)
Biogen (1) · Hoffmann-La Roche (1)
United States (2) · Spain (1) · United Kingdom (1)